Mylan ships generic version of Tricor
Mylan Inc. has released fenofibrate tablets, a treatment for high cholesterol and triglycerides, in strengths of 48 mg and 145 mg. The company said Friday that its Mylan Pharmaceuticals Inc.
CDR
Energizer ups performance of AA lithium battery
Energizer Holdings Inc. has boosted the performance of its Energizer Ultimate Lithium AA batteries, which the company said are already the longest-lasting AAs in high-tech devices.
Teva set to ship ‘dry’ allergy nasal spray
Teva Pharmaceutical Industries has been cleared by the Food and Drug Administration to market QNASL Nasal Aerosol, a "dry" nasal aerosol corticosteroid that treats seasonal and year-round nasal allergy symptoms.
Bausch+Lomb to acquire Ista Pharmaceuticals
Bausch+Lomb has unveiled a $500 million deal to acquire Ista Pharmaceuticals Inc., a maker of branded prescription drugs for eye care. Bausch+Lomb said Monday that the transaction, which has been unanimously approved by the boards of both companies, is slated to close in the second quarter.
McKesson wraps up purchase of Katz units
McKesson Corp. has closed its acquisition of the independent banner and franchise pharmacy businesses of Katz Group Canada Inc. The pharmaceutical distributor said Monday that it finalized the transaction on March 25.
Rite Aid spotlights ‘Favorite Pharmacist’ winners
Rite Aid Corp. has announced the two winners of its 2011 Favorite Pharmacist contest, including a pharmacist and a long-time customer.
CVS Caremark serves up medication adherence analysis
CVS Caremark Corp. has issued two new reports highlighting the company’s research on medication adherence, including one study that reviews and compares state-by-state adherence rates for patients managing four chronic diseases.
Walgreens sees earnings decrease in 2Q
Walgreen Co. cited a weak cold and flu season and its impasse with pharmacy benefit manager Express Scripts Inc. in reporting declined earnings and prescription sales for its fiscal 2012 second quarter. Walgreens said Tuesday that for the second quarter ended Feb.
Court upholds injunction suspending Medi-Cal cuts
The National Association of Chain Drug Stores applauded a federal court ruling that upheld an injunction blocking the implementation of cuts to Medi-Cal, California’s Medicaid program.
Loblaw acquires Rx files from 95 Zellers pharmacies
Loblaw Cos. has purchased prescription files from 95 pharmacies operated by Canadian mass merchandise chain Zellers Inc.
CACDS tracks growing reliance on pharmacists
A recent survey of pharmacy patients across Canada shows that nearly three-quarters of those polled have talked to a pharmacist about health issues beyond those related to their prescriptions.
More groups speak out against PBM merger deal
Organizations representing food retailers and wholesalers have urged the Federal Trade Commission to block the proposed acquisition of Medco Health Solutions Inc. by Express Scripts Inc.
Next frontier reached in use of patient data
Walgreen Co. has begun using Surescripts’ clinical interoperability to electronically deliver patient data to primary care providers and better coordinate care.
Rite Aid clarifies its wellness ambassador role
After two U.S. senators expressed concerns, Rite Aid Corp. has reiterated the role of its “wellness ambassador,” a key customer service feature of the drug chain’s new “wellness store” format. In press announcements this month, Sens. Richard Durbin (D., Ill.) and Richard Blumenthal (D., Conn.
Retail sales are on the upswing
Retail sales in February showed the highest gain in five months, and the industry’s largest drug chains mirrored the broader trend. At Rite Aid Corp., for instance, total sales for the five weeks ended March 3 increased 2.3% to $2.55 billion, up from $2.
CVS, Cardinal win round in DEA fight
Cardinal Health Inc. and CVS Caremark Corp. have won reprieves from the Drug Enforcement Administration’s (DEA’s) efforts to have them stop selling certain prescription drugs in Florida. In separate rulings a week apart, the U.S.